Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04101968Recruiting

The GBA Multimodal Study in Parkinson's Disease

Role: lead

NCT04426786Not ApplicableRecruiting

Exercise & Brain Energetics in PD

Role: lead

NCT04876404Completed

Somatotopy in Parkinson's Disease

Role: lead

NCT01835652Not ApplicableCompleted

The Effects of Exercise in Parkinson's Disease

Role: lead

NCT02265900Not ApplicableTerminated

Parkinson's Disease Exercise TMS PET Study

Role: lead

NCT03337464Not ApplicableCompleted

Single Exercise Bout in Parkinson's Disease (PD)

Role: lead

NCT02315781Not ApplicableTerminated

tDCS in Parkinson's Disease With Depression

Role: lead

All 7 trials loaded